. Remdesivir tied to 25% lower risk of in-hospital death in adults with COVID and no added oxygen - IOPAC Press "Enter" to skip to content

Remdesivir tied to 25% lower risk of in-hospital death in adults with COVID and no added oxygen

Use of the antiviral was linked to a significant decline in in-hospital death at both 14 and 28 days, regardless of variant of concern.